Quipt Home Medical Corp. (QIPT)
USD 2.02
(-8.18%)
USD 2.02
(-8.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 221.74 Million USD | 58.54% |
| 2022 | 139.86 Million USD | 36.65% |
| 2021 | 102.35 Million USD | 40.15% |
| 2020 | 73.02 Million CAD | 19.4% |
| 2019 | 61.16 Million CAD | 2.81% |
| 2018 | 59.49 Million CAD | -3.36% |
| 2017 | 61.56 Million CAD | -41.87% |
| 2016 | 105.9 Million CAD | 98.29% |
| 2015 | 53.41 Million CAD | 181.32% |
| 2014 | 18.98 Million CAD | 392.62% |
| 2013 | 3.85 Million CAD | -2.76% |
| 2012 | 3.96 Million CAD | 184.88% |
| 2011 | 1.39 Million CAD | 3561.2% |
| 2010 | 38 Thousand CAD | -97.57% |
| 2009 | 1.56 Million CAD | -29.23% |
| 2008 | 2.21 Million CAD | -62.47% |
| 2007 | 5.89 Million CAD | 5.04% |
| 2006 | 5.61 Million CAD | 21.99% |
| 2005 | 4.59 Million CAD | -23.03% |
| 2004 | 5.97 Million CAD | 41.85% |
| 2003 | 4.21 Million CAD | 30.73% |
| 2002 | 3.22 Million CAD | 65.66% |
| 2001 | 1.94 Million CAD | 397.93% |
| 2000 | 390.61 Thousand CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 63.66 Million USD | -2.16% |
| 2024 Q3 | 63.95 Million USD | 0.02% |
| 2024 Q1 | 67.16 Million USD | 4.54% |
| 2023 FY | 221.74 Million USD | 58.54% |
| 2023 Q3 | 60.28 Million USD | 3.72% |
| 2023 Q4 | 62.52 Million USD | 3.71% |
| 2023 Q2 | 58.12 Million USD | 42.4% |
| 2023 Q1 | 40.81 Million USD | 1.8% |
| 2022 Q4 | 40.09 Million USD | 9.27% |
| 2022 Q1 | 29.52 Million USD | 1.4% |
| 2022 FY | 139.86 Million USD | 36.65% |
| 2022 Q2 | 33.55 Million USD | 13.64% |
| 2022 Q3 | 36.69 Million USD | 9.36% |
| 2021 FY | 102.35 Million USD | 40.15% |
| 2021 Q2 | 24.24 Million USD | 6.53% |
| 2021 Q3 | 26.23 Million USD | 8.24% |
| 2021 Q4 | 29.11 Million USD | 10.98% |
| 2021 Q1 | 22.75 Million USD | 15.08% |
| 2020 Q4 | 19.77 Million CAD | 4.39% |
| 2020 FY | 73.02 Million CAD | 19.4% |
| 2020 Q2 | 16.99 Million CAD | -2.5% |
| 2020 Q1 | 17.43 Million CAD | 47.08% |
| 2020 Q3 | 18.94 Million CAD | 11.45% |
| 2019 Q1 | 15.93 Million CAD | -1.53% |
| 2019 Q2 | 16.41 Million CAD | 3.01% |
| 2019 FY | 61.16 Million CAD | 2.81% |
| 2019 Q3 | 16.09 Million CAD | -1.96% |
| 2019 Q4 | 11.85 Million CAD | -26.34% |
| 2018 Q3 | 14.99 Million CAD | 3.39% |
| 2018 Q4 | 16.17 Million CAD | 7.93% |
| 2018 FY | 59.49 Million CAD | -3.36% |
| 2018 Q1 | 14.73 Million CAD | 217.42% |
| 2018 Q2 | 14.49 Million CAD | -1.57% |
| 2017 Q4 | -12.54 Million CAD | -148.69% |
| 2017 Q1 | 23.08 Million CAD | -3.04% |
| 2017 Q3 | 25.76 Million CAD | 7.94% |
| 2017 FY | 61.56 Million CAD | -41.87% |
| 2017 Q2 | 23.87 Million CAD | 3.39% |
| 2016 Q3 | 24.95 Million CAD | -4.05% |
| 2016 Q1 | 28.95 Million CAD | 49.11% |
| 2016 FY | 105.9 Million CAD | 98.29% |
| 2016 Q4 | 23.81 Million CAD | -4.56% |
| 2016 Q2 | 26 Million CAD | -10.18% |
| 2015 FY | 53.41 Million CAD | 181.32% |
| 2015 Q2 | 10.28 Million CAD | 17.4% |
| 2015 Q4 | 19.41 Million CAD | 24.52% |
| 2015 Q3 | 15.59 Million CAD | 51.64% |
| 2015 Q1 | 8.75 Million CAD | 7.36% |
| 2014 Q4 | 8.15 Million CAD | 57.59% |
| 2014 FY | 18.98 Million CAD | 392.62% |
| 2014 Q3 | 5.17 Million CAD | 56.14% |
| 2014 Q1 | 2.21 Million CAD | 101.54% |
| 2014 Q2 | 3.31 Million CAD | 49.38% |
| 2013 Q2 | 918.24 Thousand CAD | -12.18% |
| 2013 Q4 | 1.1 Million CAD | 25.69% |
| 2013 FY | 3.85 Million CAD | -2.76% |
| 2013 Q3 | 876.17 Thousand CAD | -4.58% |
| 2013 Q1 | 1.04 Million CAD | -11.37% |
| 2012 Q2 | 922 Thousand CAD | 11.37% |
| 2012 Q4 | 1.17 Million CAD | 12.55% |
| 2012 Q3 | 1.04 Million CAD | 13.69% |
| 2012 FY | 3.96 Million CAD | 184.88% |
| 2012 Q1 | 827.88 Thousand CAD | 54.08% |
| 2011 Q3 | 456.36 Thousand CAD | 76.78% |
| 2011 FY | 1.39 Million CAD | 3561.2% |
| 2011 Q1 | 134.13 Thousand CAD | 292.53% |
| 2011 Q2 | 258.15 Thousand CAD | 92.46% |
| 2011 Q4 | 537.32 Thousand CAD | 17.74% |
| 2010 Q4 | 34.17 Thousand CAD | 792.46% |
| 2010 Q1 | 248.51 Thousand CAD | -30.28% |
| 2010 Q2 | 172.54 Thousand CAD | -30.57% |
| 2010 FY | 38 Thousand CAD | -97.57% |
| 2010 Q3 | 3828.86 CAD | -97.78% |
| 2009 FY | 1.56 Million CAD | -29.23% |
| 2009 Q4 | 356.42 Thousand CAD | -33.68% |
| 2009 Q3 | 537.46 Thousand CAD | 92.09% |
| 2009 Q2 | 279.79 Thousand CAD | -22.55% |
| 2009 Q1 | 361.26 Thousand CAD | -24.28% |
| 2008 Q3 | -2.09 Million CAD | -250.82% |
| 2008 Q2 | 1.38 Million CAD | -7.38% |
| 2008 Q1 | 1.49 Million CAD | -2.19% |
| 2008 FY | 2.21 Million CAD | -62.47% |
| 2008 Q4 | 477.12 Thousand CAD | 122.82% |
| 2007 FY | 5.89 Million CAD | 5.04% |
| 2007 Q4 | 1.53 Million CAD | -16.24% |
| 2007 Q3 | 1.82 Million CAD | 29.41% |
| 2007 Q2 | 1.41 Million CAD | -1.42% |
| 2007 Q1 | 1.43 Million CAD | 14.91% |
| 2006 FY | 5.61 Million CAD | 21.99% |
| 2006 Q2 | 1.35 Million CAD | 0.81% |
| 2006 Q1 | 1.33 Million CAD | 7.27% |
| 2006 Q3 | 1.68 Million CAD | 24.49% |
| 2006 Q4 | 1.24 Million CAD | -25.84% |
| 2005 FY | 4.59 Million CAD | -23.03% |
| 2005 Q1 | 1.17 Million CAD | -19.53% |
| 2005 Q2 | 1.17 Million CAD | 0.4% |
| 2005 Q3 | 735.97 Thousand CAD | -37.51% |
| 2005 Q4 | 1.24 Million CAD | 69.65% |
| 2004 Q2 | 1.59 Million CAD | -5.21% |
| 2004 Q3 | 1.62 Million CAD | 1.48% |
| 2004 Q4 | 1.45 Million CAD | -10.19% |
| 2004 FY | 5.97 Million CAD | 41.85% |
| 2004 Q1 | 1.68 Million CAD | 215.72% |
| 2003 Q1 | 857.86 Thousand CAD | 84.9% |
| 2003 FY | 4.21 Million CAD | 30.73% |
| 2003 Q4 | 534.45 Thousand CAD | -61.16% |
| 2003 Q3 | 1.37 Million CAD | 38.31% |
| 2003 Q2 | 994.94 Thousand CAD | 15.98% |
| 2002 Q1 | 747.71 Thousand CAD | 2.23% |
| 2002 FY | 3.22 Million CAD | 65.66% |
| 2002 Q3 | 947.79 Thousand CAD | 20.16% |
| 2002 Q4 | 463.95 Thousand CAD | -51.05% |
| 2002 Q2 | 788.8 Thousand CAD | 5.49% |
| 2001 Q4 | 731.41 Thousand CAD | 0.0% |
| 2001 FY | 1.94 Million CAD | 397.93% |
| 2000 FY | 390.61 Thousand CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -1738.809% |
| BrainsWay Ltd. | 31.78 Million USD | -597.631% |
| Cerus Corporation | 156.36 Million USD | -41.809% |
| Envoy Medical, Inc. | 316 Thousand USD | -70071.519% |
| electroCore, Inc. | 16.03 Million USD | -1283.294% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -34331.988% |
| IceCure Medical Ltd | 3.22 Million USD | -6767.203% |
| Inogen, Inc. | 315.66 Million USD | 29.753% |
| OrthoPediatrics Corp. | 148.73 Million USD | -49.088% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -9032.702% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -60651.399% |
| MaxCyte, Inc. | 41.28 Million USD | -437.062% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -11257.168% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -200122.126% |
| Orthofix Medical Inc. | 746.64 Million USD | 70.301% |
| PAVmed Inc | 2.45 Million USD | -8943.312% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -884.688% |
| RxSight, Inc. | 89.07 Million USD | -148.933% |
| Sight Sciences, Inc. | 81.05 Million USD | -173.566% |
| SI-BONE, Inc. | 138.88 Million USD | -59.658% |
| TELA Bio, Inc. | 58.45 Million USD | -279.351% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -18.504% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -1506.71% |
| Acutus Medical, Inc. | 7.16 Million USD | -2995.226% |
| Talis Biomedical Corporation | 412 Thousand USD | -53720.874% |
| Spectral AI, Inc. | 18.05 Million USD | -1128.079% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -2138.688% |
| CVRx, Inc. | 39.29 Million USD | -464.301% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -22790.536% |
| Bioventus Inc. | 512.34 Million USD | 56.72% |
| Venus Concept Inc. | 76.35 Million USD | -190.413% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -1097.893% |
| LivaNova PLC | 1.15 Billion USD | 80.777% |
| 908 Devices Inc. | 50.22 Million USD | -341.462% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 54.02% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -287712.159% |
| NeuroPace, Inc. | 65.42 Million USD | -238.946% |
| LENSAR, Inc. | 42.16 Million USD | -425.904% |
| Apyx Medical Corporation | 52.34 Million USD | -323.584% |
| Cutera, Inc. | 212.36 Million USD | -4.414% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -564.734% |
| BioSig Technologies, Inc. | 18 Thousand USD | -1231800.0% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -33.049% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -825.661% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 85.616% |
| Axonics, Inc. | 366.37 Million USD | 39.477% |
| Outset Medical, Inc. | 130.37 Million USD | -70.079% |
| IRIDEX Corporation | 51.86 Million USD | -327.504% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -62.817% |
| IRadimed Corporation | 65.56 Million USD | -238.216% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -18755.612% |
| INVO Bioscience, Inc. | 3.02 Million USD | -7241.053% |
| Telesis Bio, Inc. | 27.5 Million USD | -706.071% |
| Viemed Healthcare, Inc. | 183 Million USD | -21.165% |
| Varex Imaging Corporation | 811 Million USD | 72.658% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -222.886% |
| Dynatronics Corporation | 32.53 Million USD | -581.571% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -2455.22% |
| Semler Scientific, Inc. | 68.18 Million USD | -225.211% |
| InMode Ltd. | 492.04 Million USD | 54.935% |
| Bruker Corporation | 2.96 Billion USD | 92.52% |
| Cytosorbents Corporation | 36.34 Million USD | -510.03% |
| DexCom, Inc. | 3.62 Billion USD | 93.878% |
| Align Technology, Inc. | 3.86 Billion USD | 94.259% |
| Viveve Medical, Inc. | 6.42 Million USD | -3350.7% |
| ZimVie Inc. | 457.43 Million USD | 51.525% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -14.883% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -200122.126% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 70.344% |
| Profound Medical Corp. | 7.33 Million USD | -2924.708% |
| Insulet Corporation | 1.69 Billion USD | 86.934% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -75.877% |
| iCAD, Inc. | 17.31 Million USD | -1180.413% |
| Nuwellis, Inc. | 8.86 Million USD | -2401.602% |
| Biotricity, Inc. | 12.06 Million USD | -1738.147% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 54.993% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -3473.602% |
| PAVmed Inc. | 2.45 Million USD | -8943.312% |
| BIOLASE, Inc. | 49.16 Million USD | -351.025% |
| Beyond Air, Inc. | 1.15 Million USD | -19032.183% |
| FONAR Corporation | 102.88 Million USD | -115.526% |
| AxoGen, Inc. | 159.01 Million USD | -39.45% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 19.197% |
| Inari Medical, Inc. | 493.63 Million USD | 55.079% |
| UFP Technologies, Inc. | 400.07 Million USD | 44.574% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -1192061.29% |
| Tenon Medical, Inc. | 2.92 Million USD | -7473.156% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -3155.149% |
| AdaptHealth Corp. | 3.2 Billion USD | 93.071% |
| Sintx Technologies, Inc. | 2.62 Million USD | -8340.883% |
| NanoVibronix, Inc. | 2.28 Million USD | -9612.746% |
| Quanterix Corporation | 122.36 Million USD | -81.209% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -808.593% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -10.583% |
| TransMedics Group, Inc. | 241.62 Million USD | 8.228% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -1500.563% |
| NeuroMetrix, Inc. | 5.9 Million USD | -3657.431% |
| Hyperfine, Inc. | 11.03 Million USD | -1909.989% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -34.266% |
| Biomerica, Inc. | 5.41 Million USD | -3994.958% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -338.563% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -25.183% |